An announcement from Korro Bio (KRRO) is now available.
David L. Lucchino resigned from our Board of Directors on August 26, 2024, but will stay connected as a strategic advisor under a consulting agreement until potentially 2027, with compensation details outlined. Simultaneously, the Board underwent restructuring, reducing and then increasing its size to appoint Dr. Katharine Knobil to a newly created position. Dr. Knobil will serve on the Board and Compensation Committee with a standard compensation and indemnification agreement, without any conflicts of interest regarding her appointment.
For detailed information about KRRO stock, go to TipRanks’ Stock Analysis page.